Literature DB >> 16988557

A successful treatment of life-threatening bleeding from polycystic kidneys with antifibrinolytic agent tranexamic acid.

Bojan Vujkovac1, Miso Sabovic.   

Abstract

We describe a successful treatment of a severe, persistent bleeding from both kidneys in a patient with autosomal dominant polycystic kidney disease (ADPKD) with tranexamic acid (TXA), a potent antifibrinolytic agent. The bleeding could not be controlled by intensive conservative treatment, it became life-threatening and urgent bilateral nephrectomy was intended. Since local and systemic hyperfibrinolysis play a role in bleeding in ADPKD patients, we tried TXA treatment. In fact, the massive bleeding promptly stopped, and haematuria gradually ceased. Removal of both kidneys was prevented. After 5 days both ureters became obstructed by blood clots, but placing J-catheters in each pyelon successfully solved this complication. Our case shows that it is reasonable to try antifibrinolytic treatment with TXA in such devastating uncontrolled bleeding.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16988557     DOI: 10.1097/01.mbc.0000245293.41774.c8

Source DB:  PubMed          Journal:  Blood Coagul Fibrinolysis        ISSN: 0957-5235            Impact factor:   1.276


  4 in total

Review 1.  The Role of Tranexamic Acid in the Management of an Acutely Hemorrhaging Patient.

Authors:  Steven Davis; Aria Nawab; Christiaan van Nispen; Ali Pourmand
Journal:  Hosp Pharm       Date:  2020-02-13

2.  Tranexamic Acid treatment of life-threatening hematuria in polycystic kidney disease.

Authors:  Turki Alameel; Michael West
Journal:  Int J Nephrol       Date:  2011-06-01

3.  Rapamycin reduces kidney volume and delays the loss of renal function in a patient with autosomal-dominant polycystic kidney disease.

Authors:  Ramón Peces; Carlos Peces; Virginia Pérez-Dueñas; Emilio Cuesta-López; Sebastián Azorín; Rafael Selgas
Journal:  NDT Plus       Date:  2009-01-16

Review 4.  Tranexamic acid evidence and controversies: An illustrated review.

Authors:  Nicole Relke; Nicholas L J Chornenki; Michelle Sholzberg
Journal:  Res Pract Thromb Haemost       Date:  2021-07-14
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.